Genmab A/S Profit Margin

As of the most recent data (June 2026), GNMSF shows a profit margin of 9.74%. That compares with 41.42% in the prior-year period — down 76.5% year over year. That is above the Healthcare sector average of 9.71%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GNMSF's profit margin is now 9.74% (was 41.42%) — a 76.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Genmab A/S is outperforming or lagging.

The Healthcare sector average profit margin is about 9.71%. Genmab A/S is at 9.74%, which is higher that average. That is roughly 0.3% above the sector mean. Use the comparison chart on this page to see how GNMSF stacks up against individual peers as well.

That compares with 41.42% in the prior-year period — down 76.5% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Genmab A/S with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Genmab A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 9.74%) with ownership activity and broader fundamentals.